Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009;13(3):R64.
doi: 10.1186/cc7866. Epub 2009 May 5.

Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis

Affiliations
Randomized Controlled Trial

Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis

Philipp Kümpers et al. Crit Care. 2009.

Abstract

Introduction: Endothelial activation leading to vascular barrier breakdown denotes a devastating event in sepsis. Angiopoietin (Ang)-2, a circulating antagonistic ligand of the endothelial specific Tie2 receptor, is rapidly released from Weibel-Palade and has been identified as a non-redundant gatekeeper of endothelial activation. We aimed to study: the time course of Ang-2 release during human experimental endotoxemia; the association of Ang-2 with soluble adhesion molecules and inflammatory cytokines; and the early time course of Ang-2 release during sepsis in critically ill patients.

Methods: In 22 healthy volunteers during a 24-hour period after a single intravenous injection of lipopolysaccharide (LPS; 4 ng/kg) the following measurement were taken by immuno luminometric assay (ILMA), ELISA, and bead-based multiplex technology: circulating Ang-1, Ang-2, soluble Tie2 receptor, the inflammatory molecules TNF-alpha, IL-6, IL-8 and C-reactive protein, and the soluble endothelial adhesion molecules inter-cellular adhesion molecule-1 (ICAM-1), E-selectin, and P-selectin. A single oral dose of placebo or the p38 mitogen activated protein (MAP) kinase inhibitor drug, RWJ-67657, was administered 30 minutes before the endotoxin infusion. In addition, the course of circulating Ang-2 was analyzed in 21 septic patients at intensive care unit (ICU) admission and after 24 and 72 hours, respectively.

Results: During endotoxemia, circulating Ang-2 levels were significantly elevated, reaching peak levels 4.5 hours after LPS infusion. Ang-2 exhibited a kinetic profile similar to early pro-inflammatory cytokines TNF-alpha, IL-6, and IL-8. Ang-2 levels peaked prior to soluble endothelial-specific adhesion molecules. Finally, Ang-2 correlated with TNF-alpha levels (r = 0.61, P = 0.003), soluble E-selectin levels (r = 0.64, P < 0.002), and the heart rate/mean arterial pressure index (r = 0.75, P < 0.0001). In septic patients, Ang-2 increased in non-survivors only, and was significantly higher compared with survivors at baseline, 24 hours, and 72 hours.

Conclusions: LPS is a triggering factor for Ang-2 release in men. Circulating Ang-2 appears in the systemic circulation during experimental human endotoxemia in a distinctive temporal sequence and correlates with TNF-alpha and E-selectin levels. In addition, not only higher baseline Ang-2 concentrations, but also a persistent increase in Ang-2 during the early course identifies septic patients with unfavorable outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time course of Ang-2, cytokines, and adhesion molecules after LPS challenge in healthy subjects. (a) Concentrations of circulating angiopoietin (Ang)-2 compared with plasma levels of TNF-alpha. IL-6, IL-8, and C-reactive protein (CRP) after lipopolysaccharide (LPS) challenge in six healthy volunteers. (b) Concentrations of circulating Ang-2 compared with plasma levels of endothelial adhesion molecules E-selectin, P-selectin, and inter-cellular adhesion molecule-1 (ICAM-1) after LPS challenge in six healthy volunteers. Non-parametric analysis of variance (Friedman's test) with Dunn's test for multiple comparison (two-sided) was used to demonstrate statistical changes in Ang-2, cytokines, and adhesion molecules (y-axes denote percentage increase; baseline = 100%).
Figure 2
Figure 2
Correlation of Ang-2 with TNF-α, E-selectin and heart rate/mean arterial pressure index after LPS challenge in healthy subjects. Dot blots showing the correlation between circulating angiopoietin (Ang)-2 and (a) plasma levels of TNF-alpha, (b) plasma levels of the soluble endothelial specific adhesion molecule E-selectin, and (c) the heart rate/mean arterial pressure index (HR/MAP index) at 6.5 hours after lipopolysaccharide (LPS) challenge in 21 subjects (placebo (n = 6), and medication groups: 350 mg (n = 5). 700 mg (n = 6), and 1400 mg (n = 4), respectively). Pearsons correlation coefficient was used after logarithmic transformation of variables (axes denote percentage increase after logarithmic transformation; baseline = 100%).
Figure 3
Figure 3
Time course of Ang-2 in critically ill patients with sepsis. Dot blots showing the concentration of angiopoietin (Ang)-2 (ng/ml) in 21 septic on intensive care unit (ICU) admission, 24 hours and 72 hours after admission, respectively. Of note, median Ang-2 levels increased in non-survivors (P = 0.019) (continuous line), but remained unchanged in survivors (P = 0.83) (dotted line) during the time course. Mean Ang-2 level was higher in non-survivors (filled circles, n = 11) compared with survivors (open circles, n = 10) on admission (P = 0.032), after 24 hours (P = 0.027), and 72 hours (P = 0.008) (two-sided Mann-Whitney test).

References

    1. Vincent JL, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care. 2005;9(Suppl 4):S9–12. doi: 10.1186/cc3748. - DOI - PMC - PubMed
    1. van Meurs M, Kümpers P, Ligtenberg JJ, Mertens JH, Molema G, Zijlstra JG. Bench-to-bedside review: Angiopoietin signalling in critical illness: a future target? Crit Care. 2009;13:207. doi: 10.1186/cc7153. - DOI - PMC - PubMed
    1. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3:e46. doi: 10.1371/journal.pmed.0030046. - DOI - PMC - PubMed
    1. Heijden M van der, Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008;63:903–909. doi: 10.1136/thx.2007.087387. - DOI - PubMed
    1. Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marme D, Augustin HG. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem. 2003;278:1721–1727. doi: 10.1074/jbc.M208550200. - DOI - PubMed

Publication types

MeSH terms